FDA Approves Clinical Trial of Novel Stem Cell and Gene Therapy to Stall Progression of ALS – PR Newswire (press release)
|
FDA Approves Clinical Trial of Novel Stem Cell and Gene Therapy to Stall Progression of ALS
PR Newswire (press release) This study is the first clinical trial to use neural stem cells to deliver GDNF for ALS, an approach developed by Clive Svendsen, Ph.D., from Cedars-Sinai. It will be conducted at the ALS clinic at Cedars-Sinai Medical Center and led by Robert Baloh, M … |
